Chromatin control and cancer-drug discovery: realizing the promise

Drug Discovery Today
Adam G Inche, Nicholas B La Thangue

Abstract

Recent years have seen major advances in elucidating the complexity of chromatin and its role as an epigenetic regulator of gene expression in eukaryotes. We now have a basic understanding of chromatin control and the enzymatic modifications that impart diverse regulatory cues to the functional activity of the genome. Most importantly, although research into chromatin has uncovered fascinating insights into the control of gene expression, it has also generated a large body of information that is being harnessed to develop new therapeutic modalities for treating cancer. Here, we discuss recent advances that support the contention that future generations of chromatin-modulating drugs will provide a significant group of new, mechanism-based therapeutics for cancer.

References

May 26, 1991·The New England Journal of Medicine·R P WarrellA Jakubowski
Oct 29, 1982·Biochemical and Biophysical Research Communications·S JahangeerR C Henneberry
Jul 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·G D GinderJ K Pohlman
May 1, 1982·The Journal of Cell Biology·J AllanH Gould
Dec 6, 1994·Proceedings of the National Academy of Sciences of the United States of America·R JüttermannR Jaenisch
Mar 13, 1995·American Journal of Medical Genetics·R W Miller, J H Rubinstein
Oct 28, 1993·Nature·J C ChriviaR H Goodman
Mar 17, 1997·International Journal of Cancer. Journal International Du Cancer·M O HiltunenJ Jänne
Aug 5, 1997·Proceedings of the National Academy of Sciences of the United States of America·O M SobuloN J Zeleznik-Le
May 30, 1998·Proceedings of the National Academy of Sciences of the United States of America·J SchultzC P Ponting
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J G HermanS B Baylin
Jun 26, 1999·Science·D ChenM R Stallcup
Jan 19, 2000·Nature·B D Strahl, C D Allis
Feb 17, 2000·The EMBO Journal·M A Martínez-BalbásT Kouzarides
Mar 21, 2000·Biochimica Et Biophysica Acta·R L Schiltz, Y Nakatani
May 17, 2000·Neurochemistry International·C U Johannessen
Jun 6, 2000·Microbiology and Molecular Biology Reviews : MMBR·D E Sterner, S L Berger
Jul 15, 2000·Journal of Neuro-oncology·H NishimoriW K Cavenee
Mar 22, 2001·Molecular and Cellular Biology·P ErnstS J Korsmeyer
May 19, 2001·European Journal of Biochemistry·S R Grossman
Jun 5, 2001·Nature Reviews. Molecular Cell Biology·R Marmorstein
Jul 4, 2001·Nature Cell Biology·H M ChanN B La Thangue
Jul 20, 2001·Cell·A E McBride, P A Silver
Aug 3, 2001·Nature·S J NielsenT Kouzarides
Aug 9, 2001·Journal of Molecular Biology·R Marmorstein

❮ Previous
Next ❯

Citations

Apr 20, 2010·Cancer Chemotherapy and Pharmacology·Nighat NoureenSaima Kalsoom
Sep 4, 2012·Archives of Pharmacal Research·Woong Jae Park, Eunsook Ma
Nov 30, 2011·Immunology and Cell Biology·Omar Khan, Nicholas B La Thangue
Oct 8, 2008·Nature Clinical Practice. Oncology·Omar Khan, Nicholas B La Thangue
Mar 24, 2010·Proceedings of the National Academy of Sciences of the United States of America·Omar KhanNicholas B La Thangue
Jun 12, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L StimsonN B La Thangue
Jun 8, 2015·Current Opinion in Nephrology and Hypertension·Jinhua Tang, Shougang Zhuang
Apr 14, 2009·Cancer Letters·Lindsay Stimson, Nicholas B La Thangue
Sep 16, 2008·The International Journal of Biochemistry & Cell Biology·Antonello Mai, Lucia Altucci
Jun 18, 2015·Computational and Structural Biotechnology Journal·Federico Andreoli, Alberto Del Rio
May 26, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Addy Montes de OcaEscolastico Aguilera-Tejero
Feb 14, 2008·Medicinal Research Reviews·Yujun George ZhengMasha Goodman
Feb 19, 2013·Clinical Science·Jinhua TangShougang Zhuang
Nov 13, 2012·Molecular Oncology·Maria NewNicholas B La Thangue
Mar 15, 2006·Drug Discovery Today·Panagiotis A Konstantinopoulos, Athanasios G Papavassiliou
Oct 26, 2016·International Journal of Hematology·Weiwei QiZonghong Shao
Feb 20, 2007·Mutation Research·Timothy J Moss, Lori L Wallrath
Mar 21, 2007·Cancer Treatment Reviews·Michalis V KaramouzisAthanasios G Papavassiliou
Nov 7, 2012·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Woong Jae Park, Eunsook Ma
May 15, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Anu PrakashEmer Bourke
Oct 6, 2020·American Journal of Physiology. Renal Physiology·Wei ZhangShougang Zhuang
Sep 19, 2007·Molecular Cancer Therapeutics·Elena D EliseevaMira O Jung
Jun 11, 2009·Molecular Cancer Therapeutics·Leigh EllisRicky W Johnstone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Adenomatous Polyposis Coli

Adenomatous polyposis coli is a protein encoded by the APC gene and acts as a tumor suppressor. Discover the latest research on adenomatous polyposis coli here.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.